$MRNS Why short this. Amazing news! Buy in. Don't let greed consume you lol. NEWS - positive results from a Phase 3 clinical trial, MARIGOLD, evaluating lead drug ganaxolone in children and young adults with a rare inherited type of epilepsy with treatment-resistant seizures called CDKL5 deficiency disorder (CDD), a Rare Pediatric Disease-tagged indication.